Kirsten Mortensen, the general manager of Ferrosan Cluj Napoca, said Pfizer’s investment targets to remodel its Romanian plant as part of a global strategy. He also said Pfizer will transfer the production of several products from Soborg (Denmark), from third suppliers and from Aprilia (Italy) to Ferrosan Cluj-Napoca.
Mortensen added this is the reason behind the company’s decision to expand its storage capacities. According to him, Pfizer aims to boost production at its Ferrosan plant from 3 million packages in 2013 to 11 million in upcoming years.
Nolan Townsend, Country Manager for Pfizer Romania, said the acquisition of Ferrosan and the further expansion of the facility in Cluj is part of Pfizer’s long term strategy and demonstrates its commitment to the Romanian market.
Ferrosan is part of Pfizer’s global manufacturing and supply network. The plant currently has a production capacity of 6 million packages per year, using the existing packaging machines, and the plan is to gradually increase its capacity over the next 3 years. Currently, 124 people are working in the factory and staff numbers may increase according to the plant’s development level of the site development.
Pfizer’s investments also target the expansion of the storage area for raw materials, packaging materials and finished products. Works are due to be completed at the end of March 2015 and the total investment amounts to $5.4 million.